Data:
{
"symbol": "NAMS",
"price": 27.2432,
"marketCap": 3184838481,
"beta": 0.11,
"lastDividend": 0,
"range": "23.05-42.205",
"change": 0.3932,
"changePercentage": 1.46443,
"volume": 1405236.53508,
"averageVolume": 1221505,
"companyName": "NewAmsterdam Pharma Company N.V.",
"currency": "USD",
"cik": "0001936258",
"isin": "NL00150012L7",
"cusip": null,
"exchangeFullName": "NASDAQ",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.newamsterdampharma.com",
"description": "NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer\u2019s disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.",
"ceo": "Michael Harvey Davidson Facp.",
"sector": "Healthcare",
"country": "NL",
"fullTimeEmployees": "100",
"phone": "31 35 206 2971",
"address": "Gooimeer 2-35",
"city": "Naarden",
"state": "NH",
"zip": "1411 DC",
"image": "https://images.financialmodelingprep.com/symbol/NAMS.png",
"ipoDate": "2021-02-09",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "NAMS",
"name": "NewAmsterdam Pharma Company N.V.",
"price": 27.31,
"changePercentage": 1.71322,
"change": 0.46,
"volume": 1405216,
"dayLow": 27,
"dayHigh": 28.01,
"yearHigh": 42.205,
"yearLow": 23.05,
"marketCap": 3192647666,
"priceAvg50": 30.5108,
"priceAvg200": 33.0997,
"exchange": "NASDAQ",
"open": 27,
"previousClose": 26.85,
"timestamp": 1787682868,
"chart_vwap_daily": [
{
"t": "2026-07-15",
"v": 32.2463,
"c": 31.98
},
{
"t": "2026-07-16",
"v": 31.8455,
"c": 31.05
},
{
"t": "2026-07-17",
"v": 31.61,
"c": 31.68
},
{
"t": "2026-07-20",
"v": 30.1662,
"c": 29.67
},
{
"t": "2026-07-21",
"v": 31.5378,
"c": 32.34
},
{
"t": "2026-07-22",
"v": 31.7261,
"c": 31.7
},
{
"t": "2026-07-23",
"v": 30.858,
"c": 30.55
},
{
"t": "2026-07-24",
"v": 30.3244,
"c": 29.64
},
{
"t": "2026-07-27",
"v": 30.3932,
"c": 30.22
},
{
"t": "2026-07-28",
"v": 28.1954,
"c": 27.98
},
{
"t": "2026-07-29",
"v": 27.9362,
"c": 27.91
},
{
"t": "2026-07-30",
"v": 28.2251,
"c": 28.46
},
{
"t": "2026-07-31",
"v": 27.747,
"c": 27.79
},
{
"t": "2026-08-03",
"v": 27.3761,
"c": 27.49
},
{
"t": "2026-08-04",
"v": 27.4143,
"c": 27.55
},
{
"t": "2026-08-05",
"v": 27.0829,
"c": 27.42
},
{
"t": "2026-08-06",
"v": 27.6157,
"c": 27.67
},
{
"t": "2026-08-07",
"v": 27.8466,
"c": 27.96
},
{
"t": "2026-08-10",
"v": 27.9496,
"c": 27.98
},
{
"t": "2026-08-11",
"v": 27.8033,
"c": 27.62
},
{
"t": "2026-08-12",
"v": 27.8009,
"c": 27.83
},
{
"t": "2026-08-13",
"v": 27.3403,
"c": 26.67
},
{
"t": "2026-08-14",
"v": 26.6195,
"c": 26.98
},
{
"t": "2026-08-17",
"v": 26.8551,
"c": 26.9
},
{
"t": "2026-08-18",
"v": 27.2023,
"c": 27.25
},
{
"t": "2026-08-19",
"v": 28.2717,
"c": 28.53
},
{
"t": "2026-08-20",
"v": 27.7517,
"c": 27.78
},
{
"t": "2026-08-21",
"v": 27.8648,
"c": 27.87
},
{
"t": "2026-08-24",
"v": 26.9278,
"c": 26.85
},
{
"t": "2026-08-25",
"v": 27.611,
"c": 27.31
}
],
"vwap_summary": {
"days": 30,
"days_above": 17,
"days_below": 13,
"pct_days_above": 57,
"position": "below",
"gap_pct": -1.09,
"streak_days": 2
}
}
Data:
{
"volume": 1405216,
"avgVolume": 1221505,
"short_ratio": [
{
"symbol": "NAMS",
"file_date": "2026-08-24",
"date": "20260824",
"short_volume": 300251,
"short_exempt_volume": 50813,
"total_volume": 626680,
"short_volume_ratio": 0.4791,
"signal": "Neutral"
}
],
"volume_profile": {
"poc": 27.69,
"vah": 28.11,
"val": 27.19,
"profile": [
{
"price": 26.12,
"volume": 92276
},
{
"price": 26.16,
"volume": 15709
},
{
"price": 26.21,
"volume": 62326
},
{
"price": 26.25,
"volume": 53232
},
{
"price": 26.29,
"volume": 25495
},
{
"price": 26.34,
"volume": 109426
},
{
"price": 26.38,
"volume": 19114
},
{
"price": 26.42,
"volume": 43330
},
{
"price": 26.47,
"volume": 45415
},
{
"price": 26.51,
"volume": 15588
},
{
"price": 26.56,
"volume": 29368
},
{
"price": 26.6,
"volume": 63767
},
{
"price": 26.64,
"volume": 102036
},
{
"price": 26.69,
"volume": 88809
},
{
"price": 26.73,
"volume": 413573
},
{
"price": 26.77,
"volume": 365653
},
{
"price": 26.82,
"volume": 207758
},
{
"price": 26.86,
"volume": 323137
},
{
"price": 26.91,
"volume": 484330
},
{
"price": 26.95,
"volume": 751867
},
{
"price": 26.99,
"volume": 282524
},
{
"price": 27.04,
"volume": 122399
},
{
"price": 27.08,
"volume": 285195
},
{
"price": 27.12,
"volume": 191767
},
{
"price": 27.17,
"volume": 211246
},
{
"price": 27.21,
"volume": 223080
},
{
"price": 27.26,
"volume": 264370
},
{
"price": 27.3,
"volume": 482519
},
{
"price": 27.34,
"volume": 584691
},
{
"price": 27.39,
"volume": 431562
},
{
"price": 27.43,
"volume": 767764
},
{
"price": 27.47,
"volume": 441195
},
{
"price": 27.52,
"volume": 552573
},
{
"price": 27.56,
"volume": 651831
},
{
"price": 27.61,
"volume": 803656
},
{
"price": 27.65,
"volume": 1179244
},
{
"price": 27.69,
"volume": 1573565
},
{
"price": 27.74,
"volume": 847881
},
{
"price": 27.78,
"volume": 973145
},
{
"price": 27.82,
"volume": 795921
},
{
"price": 27.87,
"volume": 511055
},
{
"price": 27.91,
"volume": 945655
},
{
"price": 27.96,
"volume": 581041
},
{
"price": 28.0,
"volume": 584820
},
{
"price": 28.04,
"volume": 463025
},
{
"price": 28.09,
"volume": 486542
},
{
"price": 28.13,
"volume": 212596
},
{
"price": 28.17,
"volume": 98108
},
{
"price": 28.22,
"volume": 205051
},
{
"price": 28.26,
"volume": 215352
},
{
"price": 28.31,
"volume": 85939
},
{
"price": 28.35,
"volume": 152711
},
{
"price": 28.39,
"volume": 127609
},
{
"price": 28.44,
"volume": 135438
},
{
"price": 28.48,
"volume": 168684
},
{
"price": 28.52,
"volume": 38128
},
{
"price": 28.57,
"volume": 9291
},
{
"price": 28.61,
"volume": 81767
},
{
"price": 28.66,
"volume": 114493
},
{
"price": 28.7,
"volume": 1989
}
],
"sessions": 20
}
}
Data:
{
"symbol": "NAMS",
"marketCap": 3184838481,
"enterpriseValueTTM": 2768204574,
"evToSalesTTM": 387.69407119786547,
"evToOperatingCashFlowTTM": -19.243907661959266,
"evToFreeCashFlowTTM": -19.20909450884346,
"evToEBITDATTM": -10.831729223393152,
"netDebtToEBITDATTM": 1.663811705992671,
"currentRatioTTM": 9.033450269959163,
"incomeQualityTTM": 0.9695212607790663,
"grahamNumberTTM": null,
"grahamNetNetTTM": 4.691739576205061,
"taxBurdenTTM": 1,
"interestBurdenTTM": 1.0170564996551075,
"workingCapitalTTM": 586233000,
"investedCapitalTTM": 587069000,
"returnOnAssetsTTM": -0.36837712150721413,
"operatingReturnOnAssetsTTM": -0.3401403525862939,
"returnOnTangibleAssetsTTM": -0.36855657291697735,
"returnOnEquityTTM": -0.3832940998358655,
"returnOnInvestedCapitalTTM": -0.38702367680964805,
"returnOnCapitalEmployedTTM": -0.38703961183129104,
"earningsYieldTTM": -0.07721035625694155,
"freeCashFlowYieldTTM": -0.045126935277067196,
"capexToOperatingCashFlowTTM": -0.0018123266091369143,
"capexToDepreciationTTM": 1.0655737704918034,
"capexToRevenueTTM": 0.03651172588119646,
"salesGeneralAndAdministrativeToRevenueTTM": 14.354865889622245,
"researchAndDevelopementToRevenueTTM": 20.88863923606235,
"stockBasedCompensationToRevenueTTM": 4.68908861115012,
"intangiblesToTotalAssetsTTM": 0.0004869032950435232,
"averageReceivablesTTM": 16108500,
"averagePayablesTTM": 6756000,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 1229.959275382671,
"daysOfPayablesOutstandingTTM": 3540.3041144901613,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 1229.959275382671,
"cashConversionCycleTTM": -2310.3448391074903,
"freeCashFlowToEquityTTM": -143722000,
"freeCashFlowToFirmTTM": -143722000,
"tangibleAssetValueTTM": 631079000,
"netCurrentAssetValueTTM": 586177000,
"grossProfitMarginTTM": 0.9214997893554276,
"ebitMarginTTM": -35.830922623227075,
"ebitdaMarginTTM": -35.79244488133689,
"operatingProfitMarginTTM": -34.32200533632917,
"pretaxProfitMarginTTM": -36.44207274259233,
"continuousOperationsProfitMarginTTM": -36.44207274259233,
"netProfitMarginTTM": -36.44207274259233,
"bottomLineProfitMarginTTM": -36.44207274259233,
"receivablesTurnoverTTM": 0.29675779296549426,
"payablesTurnoverTTM": 0.10309848764293618,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 14.44421906693712,
"assetTurnoverTTM": 0.010108566658906498,
"quickRatioTTM": 9.033450269959163,
"solvencyRatioTTM": -3.5496371354237986,
"cashRatioTTM": 5.812357826075041,
"priceToEarningsRatioTTM": -12.526055045871558,
"priceToEarningsGrowthRatioTTM": 0.3664802013745804,
"forwardPriceToEarningsGrowthRatioTTM": 0.7183977294988155,
"priceToEarningsDilutedRatioTTM": -12.526055045871558,
"priceToEarningsDilutedGrowthRatioTTM": 0.3664802013745804,
"priceToBookRatioTTM": 5.335332394464558,
"priceToSalesRatioTTM": 448.29006796798205,
"priceToFreeCashFlowRatioTTM": -22.21144691835627,
"priceToOperatingCashFlowRatioTTM": -23.482498858078095,
"debtToAssetsRatioTTM": 0.00011640253700748952,
"debtToEquityRatioTTM": 0.00012986560493615998,
"debtToCapitalRatioTTM": 0.00012984874205072337,
"longTermDebtToCapitalRatioTTM": 0,
"financialLeverageRatioTTM": 1.1156595747376556,
"workingCapitalTurnoverRatioTTM": 0.012101735471459549,
"operatingCashFlowRatioTTM": -1.96593307205306,
"operatingCashFlowSalesRatioTTM": -20.14632776295464,
"freeCashFlowOperatingCashFlowRatioTTM": 1.001812326609137,
"debtServiceCoverageRatioTTM": 0,
"interestCoverageRatioTTM": 0,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": -1749.5365853658536,
"capitalExpenditureCoverageRatioTTM": -551.776923076923,
"dividendPaidAndCapexCoverageRatioTTM": -551.776923076923,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0.05772056909157794,
"netIncomePerShareTTM": -2.10345717757911,
"interestDebtPerShareTTM": 0.0006646660111654811,
"cashPerShareTTM": 5.137819632210792,
"bookValuePerShareTTM": 5.118106611001591,
"tangibleBookValuePerShareTTM": 5.115326361710984,
"shareholdersEquityPerShareTTM": 5.118106611001591,
"operatingCashFlowPerShareTTM": -1.1628575035831983,
"capexPerShareTTM": 0.002107477596378355,
"freeCashFlowPerShareTTM": -1.1649649811795766,
"netIncomePerEBTTTM": 1,
"ebtPerEbitTTM": 1.0617699165735843,
"priceToFairValueTTM": 5.335332394464558,
"debtToMarketCapTTM": 0,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": -10.860900407253666,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 22503000
}
],
"dcf": {
"symbol": "NAMS",
"date": "2026-08-25",
"dcf": 3.573979237878261,
"Stock Price": 27.5819
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "NAMS",
"reportedCurrency": "USD",
"cik": "0001936258",
"filingDate": "2026-02-18",
"acceptedDate": "2026-02-18 07:00:55",
"fiscalYear": "2025",
"period": "FY",
"revenue": 22503000,
"costOfRevenue": 59000,
"grossProfit": 22444000,
"researchAndDevelopmentExpenses": 141832000,
"generalAndAdministrativeExpenses": 106295000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 106295000,
"otherExpenses": 0,
"operatingExpenses": 248127000,
"costAndExpenses": 248186000,
"netInterestIncome": 27592000,
"interestIncome": 27592000,
"interestExpense": 0,
"depreciationAndAmortization": 220000,
"ebitda": -242325000,
"ebit": -242545000,
"nonOperatingIncomeExcludingInterest": 16862000,
"operatingIncome": -225683000,
"totalOtherIncomeExpensesNet": 21864000,
"incomeBeforeTax": -203819000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": -203819000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -203819000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -203819000,
"eps": -1.75,
"epsDiluted": -1.75,
"weightedAverageShsOut": 114399326,
"weightedAverageShsOutDil": 114399326
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "NAMS",
"reportedCurrency": "USD",
"cik": "0001936258",
"filingDate": "2026-02-18",
"acceptedDate": "2026-02-18 07:00:55",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 490002000,
"shortTermInvestments": 146239000,
"cashAndShortTermInvestments": 636241000,
"netReceivables": 23152000,
"accountsReceivables": 0,
"otherReceivables": 23152000,
"inventory": 0,
"prepaids": 14986000,
"otherCurrentAssets": 1321000,
"totalCurrentAssets": 675700000,
"propertyPlantEquipmentNet": 568000,
"goodwill": 0,
"intangibleAssets": 407000,
"goodwillAndIntangibleAssets": 407000,
"longTermInvestments": 0,
"taxAssets": 0,
"otherNonCurrentAssets": 92609000,
"totalNonCurrentAssets": 93584000,
"otherAssets": 0,
"totalAssets": 769284000,
"totalPayables": 8970000,
"accountPayables": 8970000,
"otherPayables": 0,
"accruedExpenses": 0,
"shortTermDebt": 136000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 3987000,
"otherCurrentLiabilities": 72694000,
"totalCurrentLiabilities": 85787000,
"longTermDebt": 66000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 0,
"totalNonCurrentLiabilities": 66000,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 85853000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 14278000,
"retainedEarnings": -762390000,
"additionalPaidInCapital": 1426750000,
"accumulatedOtherComprehensiveIncomeLoss": 4793000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 683431000,
"totalEquity": 683431000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 769284000,
"totalInvestments": 146239000,
"totalDebt": 202000,
"netDebt": -489800000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "NAMS",
"reportedCurrency": "USD",
"cik": "0001936258",
"filingDate": "2026-02-18",
"acceptedDate": "2026-02-18 07:00:55",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -203819000,
"depreciationAndAmortization": 220000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 59425000,
"changeInWorkingCapital": -7944000,
"accountsReceivables": -13280000,
"inventory": 0,
"accountsPayables": 4909000,
"otherWorkingCapital": 427000,
"otherNonCashItems": 4335000,
"netCashProvidedByOperatingActivities": -147783000,
"investmentsInPropertyPlantAndEquipment": -246000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -296733000,
"salesMaturitiesOfInvestments": 122063000,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": -174916000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 29520000,
"netCommonStockIssuance": 29520000,
"commonStockIssuance": 29520000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": 29520000,
"effectOfForexChangesOnCash": 12759000,
"netChangeInCash": -280420000,
"cashAtEndOfPeriod": 491323000,
"cashAtBeginningOfPeriod": 771743000,
"operatingCashFlow": -147783000,
"capitalExpenditure": -246000,
"freeCashFlow": -148029000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 27.3068,
"rsi": 42.288347220138306,
"sma20": 27.590840000000036,
"sma50": 30.448935999999986,
"sma200": 33.045633999999986,
"adx": 33.44825603372657,
"atr": 1.1,
"atr_pct": 4.03,
"atr_expansion_pct": -25.1,
"di_plus": 18.6,
"di_minus": 17.4,
"high_52w": 41.45,
"low_52w": 23.95,
"structure": {
"ema8": 27.463016237561103,
"ema21": 28.136974476764333,
"ema50": 29.719746613408283,
"ema200": 30.97140225587439,
"ema10": 27.519836691926812,
"ema20": 28.070524423656884,
"ema10_slope_pct": 0.12,
"ema20_slope_pct": -1.07,
"trend_dir": "chop",
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": false,
"adx_over_30": true,
"higher_highs_lows": false,
"lower_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": -3.0,
"_no_bars": false,
"macd": {
"macd": -0.871,
"signal": -1.039,
"histogram": 0.168
},
"bollinger": {
"mid": 27.59,
"upper": 28.56,
"lower": 26.62,
"width_pct": 7.05
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": -1.1,
"ret_3d": -1.7,
"ret_5d": 0.21,
"roc10_accel": -0.05,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 1.25,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 3.72,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"avg_vol_over_2m": false,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 33277705.016000003,
"avg_vol": 1221505
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"iv_contracting": false,
"oi_calls_above_price": true
},
"vals": {
"call_vol_mult": 1.3,
"iv_rank": 48.0
}
}
}
}
Data:
{
"prior_day": {
"high": 28.01,
"low": 27,
"close": 27.31,
"date": "2026-08-25"
},
"woodie_pivots": {
"PP": 27.41,
"R1": 27.81,
"S1": 26.8,
"R2": 28.42,
"S2": 26.4
},
"swing": {
"high_20d": 29.13,
"low_20d": 25.74,
"high_60d": 37.37,
"low_60d": 25.74
},
"orb": {
"high": 27.71,
"low": 27,
"date": "2026-08-25"
},
"vwap": 27.61,
"volume_profile": {
"poc": 27.69,
"vah": 28.11,
"val": 27.19,
"sessions": 20
},
"premarket": {
"date": "2026-08-25",
"high": 27.24,
"low": 26.85,
"last": 26.89,
"volume": 1250,
"gap_pct": 0.15,
"path": "08:20 27.24 -> 08:50 26.89",
"bars": 2,
"last_bar_et": "08:50"
},
"recent_daily": [
{
"d": "2026-07-22",
"o": 31.88,
"h": 32.625,
"l": 31.21,
"c": 31.7,
"v": 702046.620052
},
{
"d": "2026-07-23",
"o": 30.66,
"h": 31.31,
"l": 30.14,
"c": 30.55,
"v": 872307.519543
},
{
"d": "2026-07-24",
"o": 30.87,
"h": 31.17,
"l": 29.61,
"c": 29.64,
"v": 1093346.455842
},
{
"d": "2026-07-27",
"o": 30.11,
"h": 31.29,
"l": 30.1,
"c": 30.22,
"v": 948742.383539
},
{
"d": "2026-07-28",
"o": 30.06,
"h": 30.28,
"l": 27.81,
"c": 27.98,
"v": 890487.433833
},
{
"d": "2026-07-29",
"o": 28.25,
"h": 29.13,
"l": 27.44,
"c": 27.91,
"v": 1301217.348386
},
{
"d": "2026-07-30",
"o": 27.93,
"h": 28.72,
"l": 26.99,
"c": 28.46,
"v": 611371.565193
},
{
"d": "2026-07-31",
"o": 28.37,
"h": 28.76,
"l": 27.31,
"c": 27.79,
"v": 956633.200355
},
{
"d": "2026-08-03",
"o": 27.67,
"h": 27.89,
"l": 26.91,
"c": 27.49,
"v": 1012542.188028
},
{
"d": "2026-08-04",
"o": 27.82,
"h": 28.06,
"l": 27,
"c": 27.55,
"v": 1080434.764587
},
{
"d": "2026-08-05",
"o": 27.33,
"h": 27.845,
"l": 25.74,
"c": 27.42,
"v": 1652566.553669
},
{
"d": "2026-08-06",
"o": 27.63,
"h": 27.98,
"l": 27.3,
"c": 27.67,
"v": 1649501.05648
},
{
"d": "2026-08-07",
"o": 28.05,
"h": 28.23,
"l": 27.51,
"c": 27.96,
"v": 572011.089271
},
{
"d": "2026-08-10",
"o": 28.08,
"h": 28.97,
"l": 27.43,
"c": 27.98,
"v": 901788.481494
},
{
"d": "2026-08-11",
"o": 27.95,
"h": 28.63,
"l": 27.29,
"c": 27.62,
"v": 2343326.09733
},
{
"d": "2026-08-12",
"o": 27.945,
"h": 28.18,
"l": 27.45,
"c": 27.83,
"v": 1627510.695269
},
{
"d": "2026-08-13",
"o": 27.85,
"h": 28.03,
"l": 26.63,
"c": 26.67,
"v": 1225351.764042
},
{
"d": "2026-08-14",
"o": 26.26,
"h": 27.06,
"l": 26.01,
"c": 26.98,
"v": 959915.907851
},
{
"d": "2026-08-17",
"o": 26.93,
"h": 27.3894,
"l": 26.51,
"c": 26.9,
"v": 834973.724076
},
{
"d": "2026-08-18",
"o": 26.66,
"h": 27.82,
"l": 26.43,
"c": 27.25,
"v": 948916.950795
},
{
"d": "2026-08-19",
"o": 28,
"h": 28.76,
"l": 27.64,
"c": 28.53,
"v": 1032236.340907
},
{
"d": "2026-08-20",
"o": 28.26,
"h": 28.43,
"l": 27.53,
"c": 27.78,
"v": 744358.74007
},
{
"d": "2026-08-21",
"o": 27.99,
"h": 28.35,
"l": 27.66,
"c": 27.87,
"v": 525432.872496
},
{
"d": "2026-08-24",
"o": 27.8,
"h": 27.97,
"l": 26.6701,
"c": 26.85,
"v": 1154211.428823
},
{
"d": "2026-08-25",
"o": 27,
"h": 28.01,
"l": 27,
"c": 27.31,
"v": 1404618.535083
}
]
}
Data:
{
"estimates": [
{
"symbol": "NAMS",
"date": "2030-12-31",
"revenueLow": 236010589,
"revenueHigh": 3594204296,
"revenueAvg": 1138065545,
"ebitdaLow": -1594043989,
"ebitdaHigh": -104671640,
"ebitdaAvg": -504736623,
"ebitLow": -1594106988,
"ebitHigh": -104675777,
"ebitAvg": -504756571,
"netIncomeLow": -11267233,
"netIncomeHigh": 1410133008,
"netIncomeAvg": 370539420,
"sgaExpenseLow": 478184329,
"sgaExpenseHigh": 7282267200,
"sgaExpenseAvg": 2305850393,
"epsAvg": 3.239,
"epsHigh": 12.32641,
"epsLow": -0.09849038,
"numAnalystsRevenue": 6,
"numAnalystsEps": 4
},
{
"symbol": "NAMS",
"date": "2029-12-31",
"revenueLow": 161291210,
"revenueHigh": 2456303185,
"revenueAvg": 777761583,
"ebitdaLow": -1089380293,
"ebitdaHigh": -71533297,
"ebitdaAvg": -344940374,
"ebitLow": -1089423346,
"ebitHigh": -71536124,
"ebitAvg": -344954007,
"netIncomeLow": -5230584,
"netIncomeHigh": 654624980,
"netIncomeAvg": 172015404,
"sgaExpenseLow": 326794358,
"sgaExpenseHigh": 4976749968,
"sgaExpenseAvg": 1575833536,
"epsAvg": 1.50364,
"epsHigh": 5.72228,
"epsLow": -0.04572216,
"numAnalystsRevenue": 10,
"numAnalystsEps": 4
},
{
"symbol": "NAMS",
"date": "2028-12-31",
"revenueLow": 143682117,
"revenueHigh": 1171658406,
"revenueAvg": 402390325,
"ebitdaLow": -519635192,
"ebitdaHigh": -63723593,
"ebitdaAvg": -178461719,
"ebitLow": -519655728,
"ebitHigh": -63726112,
"ebitAvg": -178468772,
"netIncomeLow": -202707599,
"netIncomeHigh": 350653385,
"netIncomeAvg": -39737742,
"sgaExpenseLow": 291116331,
"sgaExpenseHigh": 2373913355,
"sgaExpenseAvg": 815288621,
"epsAvg": -0.37668,
"epsHigh": 3.06517,
"epsLow": -1.77193,
"numAnalystsRevenue": 12,
"numAnalystsEps": 10
},
{
"symbol": "NAMS",
"date": "2027-12-31",
"revenueLow": 17881336,
"revenueHigh": 446032175,
"revenueAvg": 156541422,
"ebitdaLow": -197817054,
"ebitdaHigh": -7930444,
"ebitdaAvg": -69426747,
"ebitLow": -197824872,
"ebitHigh": -7930757,
"ebitAvg": -69429490,
"netIncomeLow": -348877907,
"netIncomeHigh": 237369451,
"netIncomeAvg": -197776248,
"sgaExpenseLow": 36229623,
"sgaExpenseHigh": 903711979,
"sgaExpenseAvg": 317170747,
"epsAvg": -1.56343,
"epsHigh": 2.07492,
"epsLow": -3.04965,
"numAnalystsRevenue": 11,
"numAnalystsEps": 10
}
],
"price_target": {
"symbol": "NAMS",
"targetHigh": 58,
"targetLow": 45,
"targetConsensus": 51.33,
"targetMedian": 51
},
"ratings": {
"symbol": "NAMS",
"rating": "C+",
"overallScore": 2,
"discountedCashFlowScore": 3,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 5,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "NAMS",
"date": "2026-08-06",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NAMS",
"date": "2026-06-30",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NAMS",
"date": "2026-02-19",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NAMS",
"date": "2026-02-18",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NAMS",
"date": "2026-01-21",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NAMS",
"date": "2025-12-16",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NAMS",
"date": "2025-12-02",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "NAMS",
"date": "2025-11-06",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NAMS",
"date": "2025-11-05",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NAMS",
"date": "2025-10-17",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "NewAmsterdam Pharma Company N.V. $NAMS Shares Sold by Handelsbanken Fonder AB",
"url": "https://www.defenseworld.net/2026/08/16/newamsterdam-pharma-company-n-v-nams-shares-sold-by-handelsbanken-fonder-ab.html",
"source": "Defense World",
"date": "2026-08-16 03:53:33",
"summary": "Handelsbanken Fonder AB lessened its holdings in NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) by 70.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 122,400 shares of the company's s",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-company-nv-nams-shares-sold-by-handelsbanken-20260816.jpg"
},
{
"title": "NewAmsterdam Pharma Company N.V. (NAMS) Analyst/Investor Day Transcript",
"url": "https://seekingalpha.com/article/4931177-newamsterdam-pharma-company-n-v-nams-analyst-investor-day-transcript",
"source": "Seeking Alpha",
"date": "2026-08-08 23:14:00",
"summary": "NewAmsterdam Pharma Company N.V. (NAMS) Analyst/Investor Day Transcript",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-company-nv-nams-analystinvestor-day-transcript-20260808.jpg"
},
{
"title": "NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears",
"url": "https://www.marketbeat.com/instant-alerts/newamsterdam-pharma-maps-obicetrapib-strategy-as-prevail-interim-nears-2026-08-05/",
"source": "MarketBeat",
"date": "2026-08-05 13:05:35",
"summary": "NewAmsterdam Pharma NASDAQ: NAMS used its annual Investor Day to outline its cardiovascular outcomes strategy for obicetrapib, provide updates on additional clinical programs and discuss commercial preparations ahead of a potential European launch.",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-maps-obicetrapib-strategy-as-prevail-interim-nears-20260805.jpg"
},
{
"title": "NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Lags Revenue Estimates",
"url": "https://www.zacks.com/stock/news/2968634/newamsterdam-pharma-company-n-v-nams-reports-q2-loss-lags-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2968634",
"source": "Zacks Investment Research",
"date": "2026-08-05 10:57:10",
"summary": "NewAmsterdam Pharma Company N.V. (NAMS) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.48.",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-company-nv-nams-reports-q2-loss-lags-20260805.jpg"
},
{
"title": "NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results",
"url": "https://www.globenewswire.com/news-release/2026/08/05/3339184/0/en/newamsterdam-pharma-provides-corporate-update-and-reports-second-quarter-financial-results.html",
"source": "GlobeNewsWire",
"date": "2026-08-05 07:00:00",
"summary": "\u2013 Announced positive CHMP opinion recommending marketing authorization for obicetrapib and obicetrapib/ezetimibe \u2013 \u2013 PREVAIL interim analysis planned for 4Q2026 with result expected in 1Q2027 \u2013 \u2013 Topline data from RUBENS Phase 3 expected by year-end 2026 \u2013 \u2013 $678.3 million in cas",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-provides-corporate-update-and-reports-second-quarter-20260805.jpg"
},
{
"title": "NewAmsterdam Pharma to Host Investor Day on August 5, 2026",
"url": "https://www.globenewswire.com/news-release/2026/07/29/3335148/0/en/NewAmsterdam-Pharma-to-Host-Investor-Day-on-August-5-2026.html",
"source": "GlobeNewsWire",
"date": "2026-07-29 08:00:00",
"summary": "NAARDEN, The Netherlands and MIAMI, July 29, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or \u201cNewAmsterdam\u201d or the \u201cCompany\u201d), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular ",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-to-host-investor-day-on-august-5-20260729.jpg"
},
{
"title": "NewAmsterdam Pharma und die Menarini Group erhalten positive Stellungnahme des CHMP mit der Empfehlung zur Erteilung einer Zulassung f\u00fcr Ubeslo\u00ae (Obicetrapib-Monotherapie) und Evlarco\u00ae (Festsatzkombination aus Obicetrapib und Ezetimib)",
"url": "https://www.prnewswire.com/news-releases/newamsterdam-pharma-und-die-menarini-group-erhalten-positive-stellungnahme-des-chmp-mit-der-empfehlung-zur-erteilung-einer-zulassung-fur-ubeslo-obicetrapib-monotherapie-und-evlarco-festsatzkombination-aus-obicetrapib-und-ezet-302834758.html",
"source": "PRNewsWire",
"date": "2026-07-26 13:59:00",
"summary": "/PRNewswire/ -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS oder \u201eNewAmsterdam\" oder das \u201eUnternehmen\"), ein biopharmazeutisches Unternehmen in der sp\u00e4ten",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-und-die-menarini-group-erhalten-positive-stellungnahme-20260726.jpg"
},
{
"title": "NewAmsterdam Pharma: Obicetrapib Is More Than Another LDL-Lowering Pill",
"url": "https://seekingalpha.com/article/4925643-newamsterdam-pharma-obicetrapib-is-more-than-another-ldl-lowering-pill",
"source": "Seeking Alpha",
"date": "2026-07-25 23:58:33",
"summary": "NewAmsterdam Pharma offers differentiated potential with obicetrapib, targeting comprehensive cardiovascular risk reduction beyond LDL-C lowering. NAMS's valuation is elevated, reflecting pipeline potential rather than current revenues; clinical and regulatory execution, especial",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-obicetrapib-is-more-than-another-ldllowering-pill-20260725.jpg"
},
{
"title": "NewAmsterdam Pharma et le groupe Menarini re\u00e7oivent un avis favorable du CHMP recommandant l'autorisation de mise sur le march\u00e9 d'Ubeslo\u00ae (obicetrapib en monoth\u00e9rapie) et d'Evlarco\u00ae (association \u00e0 dose fixe d'obicetrapib et d'\u00e9z\u00e9timibe)",
"url": "https://www.prnewswire.com/news-releases/newamsterdam-pharma-et-le-groupe-menarini-recoivent-un-avis-favorable-du-chmp-recommandant-lautorisation-de-mise-sur-le-marche-dubeslo-obicetrapib-en-monotherapie-et-devlarco-association-a-dose-fixe-dobicetrapib-et-dezet-302834668.html",
"source": "PRNewsWire",
"date": "2026-07-25 13:39:00",
"summary": "/PRNewswire/ -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS (ou \u00ab NewAmsterdam \u00bb ou la \u00ab Soci\u00e9t\u00e9 \u00bb), une soci\u00e9t\u00e9 biopharmaceutique sp\u00e9cialis\u00e9e dans les",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-et-le-groupe-menarini-reoivent-un-avis-20260725.jpg"
},
{
"title": "NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo\u00ae (Obicetrapib Monotherapy) and Evlarco\u00ae (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)",
"url": "https://www.prnewswire.com/news-releases/newamsterdam-pharma-and-menarini-group-receive-positive-chmp-opinion-recommending-marketing-authorization-for-ubeslo-obicetrapib-monotherapy-and-evlarco-obicetrapib-plus-ezetimibe-fixed-dose-combination-302834182.html",
"source": "PRNewsWire",
"date": "2026-07-24 10:13:00",
"summary": "/PRNewswire/ -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or \"NewAmsterdam\" or the \"Company\"), a late-stage, clinical biopharmaceutical company developing",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-and-menarini-group-receive-positive-chmp-opinion-recommending-marketing-20260724.jpg"
},
{
"title": "NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026",
"url": "https://www.globenewswire.com/news-release/2026/07/01/3320530/0/en/newamsterdam-pharma-announces-upcoming-presentations-at-the-alzheimer-s-association-international-conference-aaic-2026.html",
"source": "GlobeNewsWire",
"date": "2026-07-01 08:00:00",
"summary": "NAARDEN, the Netherlands and MIAMI, July 01, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or \u201cNewAmsterdam\u201d or the \u201cCompany\u201d), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular ",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-announces-upcoming-presentations-at-the-alzheimers-association-20260701.jpg"
},
{
"title": "NewAmsterdam Pharma Company N.V. (NAMS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript",
"url": "https://seekingalpha.com/article/4913476-newamsterdam-pharma-company-n-v-nams-presents-at-goldman-sachs-47th-annual-global-healthcare",
"source": "Seeking Alpha",
"date": "2026-06-10 00:52:09",
"summary": "NewAmsterdam Pharma Company N.V. (NAMS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript",
"image": "https://images.financialmodelingprep.com/news/newamsterdam-pharma-company-nv-nams-presents-at-goldman-sachs-20260610.jpg"
},
{
"title": "NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions",
"url": "https://www.globenewswire.com/news-release/2026/06/03/3305961/0/en/NewAmsterdam-Pharma-Announces-Upcoming-Presentations-at-the-National-Lipid-Association-NLA-2026-Scientific-Sessions.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-03T12:00:00Z",
"summary": "NewAmsterdam Pharma announced it will present multiple data presentations on obicetrapib, its novel oral CETP inhibitor for cholesterol management, at the NLA 2026 Scientific Sessions in Chicago on June 11-14, 2026. The presentations will cover clinical trial safety assessments, ",
"image": "https://ml.globenewswire.com/Resource/Download/f7b8b881-9461-4712-9965-707ed3bdd573"
},
{
"title": "NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June",
"url": "https://www.globenewswire.com/news-release/2026/05/28/3302744/0/en/NewAmsterdam-Pharma-to-Participate-at-Upcoming-Investor-Conferences-in-June.html",
"source": "GlobeNewswire Inc.",
"date": "2026-05-28T12:00:00Z",
"summary": "NewAmsterdam Pharma announced that company management will participate in investor conferences including the Jefferies Global Healthcare Conference on June 3, 2026, and the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. The company is developing obicetrap",
"image": "https://ml.globenewswire.com/Resource/Download/f7b8b881-9461-4712-9965-707ed3bdd573"
},
{
"title": "NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
"url": "https://www.globenewswire.com/news-release/2026/05/01/3286241/0/en/NewAmsterdam-Pharma-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html",
"source": "GlobeNewswire Inc.",
"date": "2026-05-01T20:57:00Z",
"summary": "NewAmsterdam Pharma's Compensation Committee approved inducement grants of 50,400 share options and 15,400 restricted stock units to five new non-executive employees. The options have an exercise price of $28.43 per share with four-year vesting, while RSUs vest over three years. ",
"image": "https://ml.globenewswire.com/Resource/Download/f7b8b881-9461-4712-9965-707ed3bdd573"
},
{
"title": "NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit",
"url": "https://www.globenewswire.com/news-release/2026/02/04/3231963/0/en/NewAmsterdam-Pharma-to-Present-at-the-Guggenheim-Emerging-Outlook-Biotech-Summit.html",
"source": "GlobeNewswire Inc.",
"date": "2026-02-04T13:00:00Z",
"summary": "NewAmsterdam Pharma announced that its CFO Ian Somaiya and EVP of Investor Relations Matthew Philippe will participate in a virtual fireside chat at the Guggenheim Emerging Outlook: Biotech Summit on February 11, 2026. The company is a late-stage biopharmaceutical firm developing",
"image": "https://ml.globenewswire.com/Resource/Download/f7b8b881-9461-4712-9965-707ed3bdd573"
}
]
Data:
[
{
"symbol": "NAMS",
"date": "2026-11-04",
"epsActual": null,
"epsEstimated": -0.5,
"revenueActual": null,
"revenueEstimated": 7540109,
"lastUpdated": "2026-08-25"
},
{
"symbol": "NAMS",
"date": "2026-08-05",
"epsActual": -0.52,
"epsEstimated": -0.48191,
"revenueActual": 3700000,
"revenueEstimated": 2830250,
"lastUpdated": "2026-08-25"
},
{
"symbol": "NAMS",
"date": "2026-05-07",
"epsActual": -0.4,
"epsEstimated": -0.46,
"revenueActual": 3040000,
"revenueEstimated": 1744667,
"lastUpdated": "2026-08-07"
},
{
"symbol": "NAMS",
"date": "2026-02-18",
"epsActual": -0.63,
"epsEstimated": -0.4342,
"revenueActual": 32000,
"revenueEstimated": 2881969,
"lastUpdated": "2026-05-18"
},
{
"symbol": "NAMS",
"date": "2025-11-05",
"epsActual": -0.61,
"epsEstimated": -0.38,
"revenueActual": 348000,
"revenueEstimated": 5307804,
"lastUpdated": "2026-08-17"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "NAMS",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "NAMS",
"periods": [
{
"file_period": "202604a",
"settlement_date": "20260414",
"quantity_fails": 7651,
"price": 36.25
},
{
"file_period": "202604b",
"settlement_date": "20260420",
"quantity_fails": 1144,
"price": 34.68
},
{
"file_period": "202606a",
"settlement_date": "20260610",
"quantity_fails": 35709,
"price": 30.38
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 6500,
"price": 33.87
},
{
"file_period": "202607a",
"settlement_date": "20260708",
"quantity_fails": 1911,
"price": 36.99
},
{
"file_period": "202607b",
"settlement_date": "20260729",
"quantity_fails": 138,
"price": 27.98
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "NAMS",
"filingDate": "2026-08-14",
"transactionDate": "2026-08-10",
"reportingCik": "0002148571",
"companyCik": "0001936258",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Gunning Robert William",
"typeOfOwner": "",
"acquisitionOrDisposition": "",
"directOrIndirect": null,
"formType": "3",
"securitiesTransacted": 0,
"price": 0,
"securityName": "",
"url": "https://www.sec.gov/Archives/edgar/data/1936258/000119312526352209/0001193125-26-352209-index.htm"
},
{
"symbol": "NAMS",
"filingDate": "2026-07-22",
"transactionDate": "2026-07-20",
"reportingCik": "0002004379",
"companyCik": "0001936258",
"transactionType": "M-Exempt",
"securitiesOwned": 129353,
"reportingName": "Kooij Louise Frederika",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 80000,
"price": 11.17,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1936258/000119312526312387/0001193125-26-312387-index.htm"
},
{
"symbol": "NAMS",
"filingDate": "2026-07-22",
"transactionDate": "2026-07-20",
"reportingCik": "0002004379",
"companyCik": "0001936258",
"transactionType": "M-Exempt",
"securitiesOwned": 70494,
"reportingName": "Kooij Louise Frederika",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 80000,
"price": 11.17,
"securityName": "Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1936258/000119312526312387/0001193125-26-312387-index.htm"
},
{
"symbol": "NAMS",
"filingDate": "2026-07-22",
"transactionDate": "2026-07-20",
"reportingCik": "0002004379",
"companyCik": "0001936258",
"transactionType": "S-Sale",
"securitiesOwned": 59153,
"reportingName": "Kooij Louise Frederika",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 70200,
"price": 29.96,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1936258/000119312526312387/0001193125-26-312387-index.htm"
},
{
"symbol": "NAMS",
"filingDate": "2026-07-22",
"transactionDate": "2026-07-20",
"reportingCik": "0002004379",
"companyCik": "0001936258",
"transactionType": "M-Exempt",
"securitiesOwned": 49353,
"reportingName": "Kooij Louise Frederika",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 25000,
"price": 11.9,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1936258/000119312526312387/0001193125-26-312387-index.htm"
},
{
"symbol": "NAMS",
"filingDate": "2026-07-22",
"transactionDate": "2026-07-20",
"reportingCik": "0002004379",
"companyCik": "0001936258",
"transactionType": "S-Sale",
"securitiesOwned": 27268,
"reportingName": "Kooij Louise Frederika",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 31885,
"price": 31.05,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1936258/000119312526312387/0001193125-26-312387-index.htm"
},
{
"symbol": "NAMS",
"filingDate": "2026-07-22",
"transactionDate": "2026-07-20",
"reportingCik": "0002004379",
"companyCik": "0001936258",
"transactionType": "S-Sale",
"securitiesOwned": 24353,
"reportingName": "Kooij Louise Frederika",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2915,
"price": 31.71,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1936258/000119312526312387/0001193125-26-312387-index.htm"
},
{
"symbol": "NAMS",
"filingDate": "2026-07-22",
"transactionDate": "2026-07-20",
"reportingCik": "0002004379",
"companyCik": "0001936258",
"transactionType": "M-Exempt",
"securitiesOwned": 10000,
"reportingName": "Kooij Louise Frederika",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 25000,
"price": 11.9,
"securityName": "Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1936258/000119312526312387/0001193125-26-312387-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "NAMS",
"executed_at": "2026-08-25T18:33:03.007000Z",
"size": 1864.0,
"price": 27.25,
"premium": 50794.0,
"volume": 1864.0,
"trade_code": " "
},
{
"ticker": "NAMS",
"executed_at": "2026-08-25T18:33:02.996000Z",
"size": 945.0,
"price": 27.24,
"premium": 25741.8,
"volume": 945.0,
"trade_code": " "
},
{
"ticker": "NAMS",
"executed_at": "2026-08-25T18:33:02.999000Z",
"size": 803.0,
"price": 27.24,
"premium": 21873.719999999998,
"volume": 803.0,
"trade_code": " "
},
{
"ticker": "NAMS",
"executed_at": "2026-08-25T18:33:03.054000Z",
"size": 700.0,
"price": 27.24,
"premium": 19068.0,
"volume": 700.0,
"trade_code": " "
},
{
"ticker": "NAMS",
"executed_at": "2026-08-25T18:33:03.007000Z",
"size": 426.0,
"price": 27.25,
"premium": 11608.5,
"volume": 426.0,
"trade_code": "F"
},
{
"ticker": "NAMS",
"executed_at": "2026-08-25T18:33:03.007000Z",
"size": 426.0,
"price": 27.24,
"premium": 11604.24,
"volume": 426.0,
"trade_code": " "
},
{
"ticker": "NAMS",
"executed_at": "2026-08-25T18:33:03.007000Z",
"size": 426.0,
"price": 27.24,
"premium": 11604.24,
"volume": 426.0,
"trade_code": " "
},
{
"ticker": "NAMS",
"executed_at": "2026-08-25T18:33:03.007000Z",
"size": 400.0,
"price": 27.24,
"premium": 10896.0,
"volume": 400.0,
"trade_code": " "
}
],
"ats": {
"symbol": "NAMS",
"date": "20260824",
"ats_volume": 0,
"total_volume": 626680,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260824",
"ats_ratio": 0.0
},
{
"date": "20260821",
"ats_ratio": 0.0
},
{
"date": "20260820",
"ats_ratio": 0.0
},
{
"date": "20260819",
"ats_ratio": 0.0
},
{
"date": "20260818",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "NAMS",
"days": [
{
"date": "2026-08-25",
"close": 27.31,
"vwap": 27.61,
"volume": 1404618,
"vwap_discount_pct": 1.1
},
{
"date": "2026-08-24",
"close": 26.85,
"vwap": 26.93,
"volume": 1154211,
"vwap_discount_pct": 0.29
},
{
"date": "2026-08-21",
"close": 27.87,
"vwap": 27.86,
"volume": 525432,
"vwap_discount_pct": -0.02
},
{
"date": "2026-08-20",
"close": 27.78,
"vwap": 27.75,
"volume": 744358,
"vwap_discount_pct": -0.1
},
{
"date": "2026-08-19",
"close": 28.53,
"vwap": 28.27,
"volume": 1032236,
"vwap_discount_pct": -0.91
}
],
"avg_vwap_discount_pct": 0.07,
"signal": "Neutral"
},
"options_flow": [
{
"price": "1.35",
"nbbo_bid": "1.35",
"strike": "25",
"open_interest": 125,
"size": 101,
"nbbo_ask": "1.55",
"option_chain_id": "NAMS260918P00025000",
"premium": "13635.00",
"option_type": "put",
"underlying_price": "27.605",
"expiry": "2026-09-18",
"sector": "Healthcare",
"implied_volatility": "0.91701091050912",
"underlying_symbol": "NAMS",
"executed_at": "2026-08-25T15:35:44.623000Z",
"volume": 317,
"delta": "-0.2912613020608558"
}
],
"net_premium": {
"ticker": "NAMS",
"net_call_premium": "31869.00",
"net_put_premium": "45005.00",
"call_premium": "50910.00",
"put_premium": "174185.00",
"bullish_premium": "105092.00",
"bearish_premium": "118228.00",
"put_call_ratio": "6.2557077625570776",
"iv_rank": "48.3623",
"implied_move_perc": "0.166000",
"gex_ratio": "4.2722532670028839",
"gex_net_change": "2061.4801",
"gex_call": "11569.3271",
"gex_put": "-49427.0955",
"gex_net": -37857.7684,
"gex_call_delta": "306879.8363",
"gex_put_delta": "-735167.7973",
"gex_date": "2026-08-25"
},
"hot_chains": [
{
"underlying_symbol": "NAMS",
"expires": "2026-09-18",
"open_interest": 125,
"option_type": "put",
"delta": -0.287468658383246,
"ask_volume": 862,
"last_price": "1.10",
"implied_volatility": "0.7705597844816",
"gamma": 0.0692390136946325,
"avg_price": "1.2616143170197224251278305335",
"bid_volume": 507,
"nbbo_ask": "1.15",
"strike": "25",
"option_symbol": "NAMS260918P00025000",
"total_premium": "172715.00",
"iv": 0.704487725067077,
"volume": 1369,
"nbbo_bid": "1.00"
},
{
"underlying_symbol": "NAMS",
"expires": "2026-11-20",
"open_interest": 200,
"option_type": "call",
"delta": 0.308504732968982,
"ask_volume": 163,
"last_price": "2.15",
"implied_volatility": "0.801456241568694",
"gamma": 0.035183867419829,
"avg_price": "2.1395999999999999999999999998",
"bid_volume": 36,
"nbbo_ask": "2.35",
"strike": "35",
"option_symbol": "NAMS261120C00035000",
"total_premium": "42792.00",
"iv": 0.752493976807984,
"volume": 200,
"nbbo_bid": "2.05"
},
{
"underlying_symbol": "NAMS",
"expires": "2026-09-18",
"open_interest": 274,
"option_type": "call",
"delta": 0.332222708328309,
"ask_volume": 11,
"last_price": "1.30",
"implied_volatility": "0.762599726572427",
"gamma": 0.0721829473718886,
"avg_price": "1.3876923076923076923076923077",
"bid_volume": 2,
"nbbo_ask": "1.50",
"strike": "30",
"option_symbol": "NAMS260918C00030000",
"total_premium": "1804.00",
"iv": 0.71981400279217,
"volume": 13,
"nbbo_bid": "1.15"
},
{
"underlying_symbol": "NAMS",
"expires": "2026-10-16",
"open_interest": 0,
"option_type": "call",
"delta": 0.418968572968002,
"ask_volume": 0,
"last_price": "2.62",
"implied_volatility": "0.833190903647953",
"gamma": 0.0509690219856598,
"avg_price": "2.62",
"bid_volume": 2,
"nbbo_ask": "2.90",
"strike": "30",
"option_symbol": "NAMS261016C00030000",
"total_premium": "524.00",
"iv": 0.745630093106314,
"volume": 2,
"nbbo_bid": "2.35"
},
{
"underlying_symbol": "NAMS",
"expires": "2027-02-19",
"open_interest": 7,
"option_type": "call",
"delta": 0.828055825160231,
"ask_volume": 2,
"last_price": "14.60",
"implied_volatility": "1.419991201720295",
"gamma": 0.00885300686005066,
"avg_price": "14.4000",
"bid_volume": 0,
"nbbo_ask": "15.40",
"strike": "17.5",
"option_symbol": "NAMS270219C00017500",
"total_premium": "2880.00",
"iv": 1.514274421733571,
"volume": 2,
"nbbo_bid": "14.20"
},
{
"underlying_symbol": "NAMS",
"expires": "2027-02-19",
"open_interest": 7,
"option_type": "call",
"delta": 0.862523502588622,
"ask_volume": 0,
"last_price": "15.60",
"implied_volatility": "1.343124233114157",
"gamma": 0.00734353733260978,
"avg_price": "15.60",
"bid_volume": 0,
"nbbo_ask": "17.00",
"strike": "15",
"option_symbol": "NAMS270219C00015000",
"total_premium": "1560.00",
"iv": 1.57440842645852,
"volume": 1,
"nbbo_bid": "15.60"
},
{
"underlying_symbol": "NAMS",
"expires": "2027-02-19",
"open_interest": 5,
"option_type": "call",
"delta": 0.791132019967748,
"ask_volume": 1,
"last_price": "13.50",
"implied_volatility": "1.423530745811915",
"gamma": 0.01043996106509046,
"avg_price": "13.50",
"bid_volume": 0,
"nbbo_ask": "14.50",
"strike": "20",
"option_symbol": "NAMS270219C00020000",
"total_premium": "1350.00",
"iv": 1.44723624788211,
"volume": 1,
"nbbo_bid": "11.60"
},
{
"underlying_symbol": "NAMS",
"expires": "2028-01-21",
"open_interest": 781,
"option_type": "put",
"delta": -0.303966747527984,
"ask_volume": 1,
"last_price": "14.70",
"implied_volatility": "1.166796503763508",
"gamma": 0.01080157313727362,
"avg_price": "14.70",
"bid_volume": 0,
"nbbo_ask": "14.70",
"strike": "30",
"option_symbol": "NAMS280121P00030000",
"total_premium": "1470.00",
"iv": 1.002315641217932,
"volume": 1,
"nbbo_bid": "13.60"
}
],
"gamma_profile": {
"ticker": "NAMS",
"spot": 27.32,
"date": "2026-08-25",
"flip_point": 22.71,
"net_gex": -37857.77,
"call_walls": [
{
"strike": 35.0,
"gex": 5977.68
},
{
"strike": 20.0,
"gex": 1981.73
},
{
"strike": 30.0,
"gex": 1823.3
}
],
"put_walls": [
{
"strike": 30.0,
"gex": -24228.87
},
{
"strike": 25.0,
"gex": -22463.33
},
{
"strike": 35.0,
"gex": -2287.99
}
],
"by_strike": [
{
"strike": 15.0,
"call_gex": 25.66,
"put_gex": -11.56,
"net_gex": 14.1
},
{
"strike": 17.5,
"call_gex": 62.99,
"put_gex": -16.65,
"net_gex": 46.34
},
{
"strike": 20.0,
"call_gex": 1981.73,
"put_gex": -82.68,
"net_gex": 1899.05
},
{
"strike": 22.5,
"call_gex": 10.69,
"put_gex": -99.74,
"net_gex": -89.05
},
{
"strike": 25.0,
"call_gex": 584.87,
"put_gex": -22463.33,
"net_gex": -21878.47
},
{
"strike": 30.0,
"call_gex": 1823.3,
"put_gex": -24228.87,
"net_gex": -22405.57
},
{
"strike": 35.0,
"call_gex": 5977.68,
"put_gex": -2287.99,
"net_gex": 3689.68
},
{
"strike": 40.0,
"call_gex": 407.83,
"put_gex": -196.33,
"net_gex": 211.5
},
{
"strike": 45.0,
"call_gex": 302.28,
"put_gex": -32.09,
"net_gex": 270.19
},
{
"strike": 50.0,
"call_gex": 152.12,
"put_gex": -2.59,
"net_gex": 149.53
},
{
"strike": 55.0,
"call_gex": 199.79,
"put_gex": -3.95,
"net_gex": 195.84
},
{
"strike": 60.0,
"call_gex": 40.4,
"put_gex": -1.32,
"net_gex": 39.08
}
]
},
"oi_changes": {
"net_call_oi_change": 7,
"net_put_oi_change": 0,
"top": [
{
"strike": "35",
"oi_change": 11,
"type": "call"
},
{
"strike": "30",
"oi_change": -4,
"type": "call"
},
{
"strike": "25",
"oi_change": 0,
"type": "put"
},
{
"strike": "30",
"oi_change": 0,
"type": "put"
},
{
"strike": "20",
"oi_change": 0,
"type": "call"
}
]
}
}
Data:
{
"vix": 16.01,
"sp500": 7641.16,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.5,
"hy_spread": 2.73,
"treasury": {
"date": "2026-08-21",
"month1": 3.8,
"month2": 3.8,
"month3": 3.88,
"month6": 3.95,
"year1": 4.03,
"year2": 4.24,
"year3": 4.31,
"year5": 4.43,
"year7": 4.57,
"year10": 4.74,
"year20": 5.25,
"year30": 5.27
},
"events": [
{
"title": "Core PCE Price Index m/m",
"currency": "USD",
"date": "2026-08-26",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.2%",
"previous": "0.1%",
"actual": null,
"minutes_until": 1116
},
{
"title": "Prelim GDP q/q",
"currency": "USD",
"date": "2026-08-26",
"time_utc": "12:30",
"impact": "High",
"forecast": "1.5%",
"previous": "1.5%",
"actual": null,
"minutes_until": 1116
},
{
"title": "Fed Chairman Warsh Speaks",
"currency": "USD",
"date": "2026-08-28",
"time_utc": "14:00",
"impact": "High",
"forecast": null,
"previous": null,
"actual": null,
"minutes_until": 4086
},
{
"title": "Prelim Benchmark Payrolls Revision",
"currency": "USD",
"date": "2026-08-28",
"time_utc": "14:00",
"impact": "High",
"forecast": null,
"previous": "-911K",
"actual": null,
"minutes_until": 4086
}
]
}
Data:
{
"days": 103,
"patterns": [
{
"name": "VWAP Touch",
"count": 103,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 97,
"pct": 94
},
{
"name": "Woodie Pivot Touch",
"count": 96,
"pct": 93
},
{
"name": "PDH/PDL Touch",
"count": 90,
"pct": 87
},
{
"name": "Gap Fill",
"count": 79,
"pct": 77
},
{
"name": "Open Retracement",
"count": 77,
"pct": 75
},
{
"name": "High Vol Open",
"count": 32,
"pct": 31
},
{
"name": "Darvas Box",
"count": 30,
"pct": 29
},
{
"name": "Power Hour",
"count": 18,
"pct": 17
}
]
}